The company’s second US LDT adds automated qFibrosis® analysis with stain-free SHG imaging, providing continuous, reproducible scores that cut inter-reader variability and support earlier, more personalised care. ...
PrecivityAD2 blood test is now available in over seven additional countries, with a primary focus on regions with inadequate PET infrastructure...
Project will leverage Ignite Proteomics’ reverse-phase protein array (RPPA) platform to profile tumour-immune signalling in breast cancer samples...
Acquisition will Accelerate Global Expansion of Company’s Breakthrough Edison® Histotripsy Platform and Non-Invasive Tumor Therapy ...
New system empowers sterile processing departments with the fastest FDA-cleared readout on the market, enabling real-time decision-making and elevating operational efficiency. ...
Regulatory milestone supports China’s reproductive health goals by enabling radiation-free, high-accuracy ultrasound imaging to assess fallopian tube patency and uterine abnormalities in women. ...
Regulatory green light marks full commercial launch of LungVision, enhancing early lung cancer detection through AI-driven 3D imaging for more precise bronchoscopic diagnostics....
Dr Ashton Harper, Global Medical Affairs Lead for Neurosciences at Roche Diagnostics, discusses how the CE-marked blood test enhances early detection, reduces invasive diagnostics, and aligns with the advent of disease-modifying therapies....
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System ...
BMI OrganBank is developing novel medical devices with potential to significantly reduce the waitlist for lifesaving organ transplants, beginning with kidneys...
